MedTrace Logo

Use of Copeptin in Diabetes Insipidus

NCT01940614 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2018-04-17

No results posted yet for this study

Summary

Prospective evaluation of the novel biomarker copeptin in the differential diagnosis of diabetes insipidus against the standard diagnostic test methods.

Conditions

  • Diabetes Insipidus
  • Primary Polydipsia

Interventions

OTHER

Water deprivation test

Classical water deprivation test alone

OTHER

Water deprivation test

classical water deprivation test plus plasma copeptin cut-off levels

OTHER

Hypertonic saline infusion

hypertonic saline infusion test plus plasma copeptin measurement

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Mirjam Christ-Crain · University Hospital

Eligibility

Min Age
16 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2017-06-30
Completion
2017-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01940614 on ClinicalTrials.gov